Cytogenetic biomonitoring in mucopolyssacharosis I, II and IV patients treated with enzyme replacement therapy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Toxicology Mechanisms and Methods

• Publication date

  2014-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/15376516.2014.956913PMID 25141890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Newborn screening and diagnosis of mucopolysaccharidoses.

  2013cited by this paper
• Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.

  2013cited by this paper
• Anthropometric characteristics of four Polish children with mucopolysaccharidosis

  2013cited by this paper
• Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms

  2012cited by this paper
• DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy.

  2011cited by this paper
• Genomic instability in blood cells from murine model of mucopolysaccharidosis type I

  2011cited by this paper
• Prevention by L-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro.

  2010cited by this paper
• Mucopolysaccharidosis VI

  2010cited by this paper
• Rare diseases research in Europe: an overview based on data from the Orphanet database

  2010cited by this paper
• Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience

  2010cited by this paper
• Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.

  2009cited by this paper
• Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.

  2008cited by this paper
• DNA damage and cellular death in oral mucosa cells of children who have undergone panoramic dental radiography

  2007cited by this paper
• Frequency of micronucleated exfoliated cells in oral lichen planus.

  2007influential reference
• Lysosomal labilization

  2006cited by this paper
• Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation.

  2006cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00)

  2004cited by this paper
• Enzyme replacement and enhancement therapies for lysosomal diseases

  2004cited by this paper
• Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases.

  2004cited by this paper
• Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.

  2003cited by this paper
• Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.

  2003cited by this paper
• Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat.

  2002cited by this paper
• Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment.

  2001cited by this paper
• Nicotine inhibits UV-induced activation of the apoptotic pathway.

  2001cited by this paper
• Comparative evaluation of the in vitro micronucleus test and the comet assay for the detection of genotoxic effects of X-ray radiation.

  2000cited by this paper
• Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing

  2000influential reference
• Incidence of the mucopolysaccharidoses in Northern Ireland

  1997cited by this paper
• Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism

  1997influential reference
• Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells.

  1995influential reference
• Registries of congenital anomalies: EUROCAT.

  1993cited by this paper
• Cell Proliferation and Chemical Carcinogenesis: summary and future directions

  1993cited by this paper
• Micronuclei and other nuclear anomalies in buccal smears: methods development.

  1992cited by this paper
• Differentiation of mucopolysaccharidoses by analyses of the excreted sulfated mucopolysaccharides.

  1977influential reference
• The Mucopolysaccharidoses

  1976cited by this paper

• Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA

  2024cites this paper
• Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations

  2020cites this paper
• Genomic Instability in Peripheral Blood and Buccal Mucosal Cells of Marijuana Smokers: The Impact of Tobacco Smoke

  2020cites this paper
• Hunter syndrome: Long-term idursulfase treatment does not protect patients against DNA oxidation and cytogenetic damage.

  2018cites this paper
• Genotoxicity and cytotoxicity induced by eluates from orthodontic glass ionomer cements in vitro

  2017cites this paper
• Clinical application of micronucleus test in exfoliated buccal cells: A systematic review and metanalysis.

  2015cites this paper